Maricann Group Inc Stock Deutsche Boerse AG
Equities
CA5667241007
Pharmaceuticals
Sales 2016 | 4.06 3.74 | Sales 2017 | 3.22 2.97 | Capitalization | 203M 187M |
---|---|---|---|---|---|
Net income 2016 | -8M -7.38M | Net income 2017 | -67M -61.77M | EV / Sales 2016 * | - |
Net Debt 2016 | 9.13 8.42 | Net cash position 2017 | 0.42 0.39 | EV / Sales 2017 | 63,046,727 x |
P/E ratio 2016 * |
-
| P/E ratio 2017 |
-2.13
x | Employees | - |
Yield 2016 * |
-
| Yield 2017 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Ben Ward
CEO | Chief Executive Officer | 44 | - |
Dan Healey
COO | Chief Operating Officer | - | - |
Steven Bennett
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Ben Ward
CEO | Chief Executive Officer | 44 | - |
1st Jan change | Capi. | |
---|---|---|
+42.07% | 6.23B | |
-21.20% | 4.19B | |
+5.38% | 3.32B | |
-16.98% | 2.91B | |
-5.82% | 2.42B | |
+45.47% | 1.94B | |
-12.67% | 1.59B | |
-3.91% | 1.58B | |
+44.56% | 1.49B |